Back to newsIonis Pharmaceuticals target price cut to $79 from $84IIONS•2026-10-20Raymond James cut its target price for Ionis Pharmaceuticals to $79 from $84.Related NewsSScholar Rock sets third-quarter financial results releaseSRRK•2026-10-20WMorning News Call - Canada, October 20WCN•2026-10-20GGold miners fall as bullion prices edge lowerGLD•2026-10-20VVisa, BILL and Billtrust launch AI agent invoice payment pilotV•2026-10-20SSoluna Holdings elects Dan Golding to board of directorsSLNH•2026-10-20
IONS•IONS•IONS•IONS•
